TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/6/20 17:00 | 1/2/20 | OCX | Oncocyte Corp | CA | Health | BioPrd | Biological Products, (No Diag | Lineage Cell Therapeutics, Inc. | CA | H | Previous | S | -5,138 | 2.16 | 0 | -2,383 | -28 | 6,041 | D | ||||||||||||||
9/13/19 17:20 | 9/11/19 | OCX | Oncocyte Corp | CA | Health | BioPrd | Biological Products, (No Diag | Lineage Cell Therapeutics, Inc. | CA | T | S | -6,640 | 1.66 | 0 | -4,000 | -32 | 8,424 | D | |||||||||||||||
7/5/19 16:32 | 7/5/19 | OCX | Oncocyte Corp | CA | Health | BioPrd | Biological Products, (No Diag | Biotime Inc | CA | T | S | -4,500 | 2.00 | 0 | -2,250 | -15 | 12,424 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |